On 15 July, Barcelona Global presented the second edition of the Scale-Up Monitor to the High Commissioner for Spain Entrepreneurial Nation, Francisco Polo, with a study that highlights Barcelona's strengths and weaknesses as a centre for technology-based scale-ups.
Those taking part in the event included Jordi Nicolau, Director of Retail and Customer Experience at CaixaBank; Aurora Catà, President of Barcelona Global; Mateu Hernández, CEO of Barcelona Global; Cristina H. Valiñani, Director of Projects at Barcelona Global; and around thirty stakeholders in the entrepreneurial ecosystem, such as CataloniaBio & HealthTech, represented by its CEO Judit Anido.
Barcelona is ranked among the best cities in Europe for entrepreneurship by many international indicators and rankings, but this edition of the Scale-Up Monitor highlights the urgency of certain actions to achieve a more competitive tax system that is not an obstacle to investment, as well as an improvement in administrative procedures and more effort in the training of the talent needed by scale-ups.
The study was carried out in collaboration with CaixaBank and with the methodological support of IESE. During the drafting process involving surveys and focus groups, CataloniaBio & HealthTech has provided knowledge on entrepreneurship in biomedicine and healthcare, as one of the main entrepreneurial sectors in Barcelona and Catalonia, along with companies such as IOMED (digital health), Minoryx Therapeutics (biotechnology), Neuroelectrics (medical technology) and Reig Jofre (pharmaceutical).
Comments